| Cardiopulmonary and cerebral resuscitation. | |
| | |
MedLine Citation:
|
PMID: 11070810 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The future of cardiopulmonary resuscitation lies in new technologies for monitoring and generating vital organ perfusion during cardiac arrest and the post-resuscitation phase and in pharmacologic agents that will enhance ROSC and reverse ischemia-reperfusion injury. ROSC is the first step toward survival, so interventions that improve ROSC deserve further investigation. Long-term survival with good neurologic recovery is the critical endpoint. Interventions recommended for clinical practice must therefore demonstrate improved long-term survival. The resources required to provide many of the interventions discussed in this article, principally invasive perfusion technologies, cannot be justified unless there is clear benefit. The allocation of such resources to provide intensive resuscitation and post-resuscitation support will need to be addressed from medical and societal viewpoints. |
| | |
Authors:
|
J E Manning; L M Katz |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Critical care clinics Volume: 16 ISSN: 0749-0704 ISO Abbreviation: Crit Care Clin Publication Date: 2000 Oct |
Date Detail:
|
Created Date: 2001-03-09 Completed Date: 2001-05-31 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 8507720 Medline TA: Crit Care Clin Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 659-79 Citation Subset: IM |
Affiliation:
|
Department of Emergency Medicine, University of North Carolina School of Medicine, Chapel Hill, USA. jmanning@med.unc.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anti-Arrhythmia Agents
/
therapeutic use Brain Ischemia / prevention & control* Cardiopulmonary Resuscitation / methods*, trends Heart Arrest / therapy* Humans Intensive Care Units* Monitoring, Physiologic / methods Myocardial Ischemia / prevention & control* Vasoconstrictor Agents / therapeutic use |
| Chemical | |
Reg. No./Substance:
|
0/Anti-Arrhythmia Agents; 0/Vasoconstrictor Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Pharmacy technology of the ICU. Today and tomorrow.
Next Document: Bioartificial organ support for hepatic, renal, and hematologic failure.